TAAR 6 and HSP-70 variations associated with bipolar disorder

[1]  T. Gasser.  Molecular pathogenesis of Parkinson disease: insights from genetic studies , 2009, Expert Reviews in Molecular Medicine.

[2]  A. Serretti,et al.  The Impact of Heat Shock Protein 70 Gene Variations on Clinical Presentation and Outcome in Schizophrenic Inpatients , 2009, Neuropsychobiology.

[3]  W. Drevets,et al.  Bipolar and major depressive disorder: Neuroimaging the developmental-degenerative divide , 2009, Neuroscience & Biobehavioral Reviews.

[4]  K. Moudgil,et al.  Heat-shock proteins can promote as well as regulate autoimmunity. , 2009, Autoimmunity reviews.

[5]  D. Laaksonen,et al.  Heat shock proteins in diabetes and wound healing. , 2009, Current protein & peptide science.

[6]  A. Serretti,et al.  Common genetic, clinical, demographic and psychosocial predictors of response to pharmacotherapy in mood and anxiety disorders , 2009, International clinical psychopharmacology.

[7]  J. Ormel,et al.  Investigating the Molecular Basis of Major Depressive Disorder Etiology , 2008, Annals of the New York Academy of Sciences.

[8]  K. Lovibond,et al.  Impact of bipolar disorder in employed populations. , 2008, The American journal of managed care.

[9]  D. Glahn,et al.  Cognitive impairment in bipolar disorder: Neurodevelopment or neurodegeneration? An ECNP expert meeting report , 2008, European Neuropsychopharmacology.

[10]  A. Bolhassani,et al.  Heat-shock proteins as powerful weapons in vaccine development , 2008, Expert review of vaccines.

[11]  R. Currie,et al.  Heat shock proteins 27 and 70 regulating angiotensin II-induced NF-kappaB: a possible connection to blood pressure control? , 2008, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.

[12]  A. Serretti,et al.  TAAR6 variation effect on clinic presentation and outcome in a sample of schizophrenic in-patients: An open label study , 2008, European Psychiatry.

[13]  A. Danese.  Genetic opportunities for psychiatric epidemiology: on life stress and depression , 2008, Epidemiologia e Psichiatria Sociale.

[14]  R. Henning,et al.  Heat shock proteins as molecular targets for intervention in atrial fibrillation. , 2008, Cardiovascular research.

[15]  D. Porteous.  Genetic causality in schizophrenia and bipolar disorder: out with the old and in with the new. , 2008, Current opinion in genetics & development.

[16]  M. Escamilla,et al.  Genetics of bipolar disorder , 2008, Dialogues in clinical neuroscience.

[17]  R. Kessler,et al.  Clinical and Economic Effects of Unrecognized or Inadequately Treated Bipolar Disorder , 2008, Journal of psychiatric practice.

[18]  B. Bay,et al.  Heat shock proteins as novel therapeutic targets in cancer. , 2008, In vivo.

[19]  I. Komuro,et al.  Role of heat shock transcriptional factor 1 and heat shock proteins in cardiac hypertrophy. , 2008, Trends in cardiovascular medicine.

[20]  A. Serretti,et al.  The genetics of bipolar disorder: genome ‘hot regions,’ genes, new potential candidates and future directions , 2008, Molecular Psychiatry.

[21]  B. Bay,et al.  Heat Shock Proteins and Neurodegenerative Disorders , 2008, TheScientificWorldJournal.

[22]  A. Serretti,et al.  Association analysis of heat shock protein 70 gene polymorphisms in schizophrenia , 2008, European Archives of Psychiatry and Clinical Neuroscience.

[23]  R. McIntyre,et al.  Bipolar disorder and suicide: Research synthesis and clinical translation , 2008, Current psychiatry reports.

[24]  A. Serretti,et al.  Heat-shock protein-70 genes and response to antidepressants in major depression , 2007, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[25]  Patrick F. Sullivan,et al.  Spurious Genetic Associations , 2007, Biological Psychiatry.

[26]  Edgar Erdfelder,et al.  G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences , 2007, Behavior research methods.

[27]  Nick Craddock,et al.  Phenotypic and genetic complexity of psychosis , 2007, British Journal of Psychiatry.

[28]  A. Serretti,et al.  Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients , 2007, Molecular Psychiatry.

[29]  A. Serretti,et al.  Serotonin transporter gene variants and behavior: a comprehensive review. , 2006, Current drug targets.

[30]  Peter Kochunov,et al.  Cortical sulci and bipolar disorder , 2006, Neuroreport.

[31]  T. Hicks,et al.  The mysterious trace amines: Protean neuromodulators of synaptic transmission in mammalian brain , 2006, Progress in Neurobiology.

[32]  J. Weissman,et al.  Molecular Chaperones and Protein Quality Control , 2006, Cell.

[33]  T. Whitford,et al.  Diagnosis-Related Regional Gray Matter Loss Over Two Years in First Episode Schizophrenia and Bipolar Disorder , 2005, Biological Psychiatry.

[34]  N. Craddock,et al.  The beginning of the end for the Kraepelinian dichotomy , 2005, British Journal of Psychiatry.

[35]  E. Solary,et al.  Heat shock proteins, cellular chaperones that modulate mitochondrial cell death pathways. , 2003, Biochemical and biophysical research communications.

[36]  Francis J McMahon,et al.  Suggestive linkage to chromosomal regions 13q31 and 22q12 in families with psychotic bipolar disorder. , 2003, The American journal of psychiatry.

[37]  P. Sullivan,et al.  Genetic case-control association studies in neuropsychiatry. , 2001, Archives of general psychiatry.

[38]  G. Moore,et al.  Bipolar disorder: leads from the molecular and cellular mechanisms of action of mood stabilisers , 2001, British Journal of Psychiatry.

[39]  R. Fieve,et al.  Lithium therapy at the millennium: a revolutionary drug used for 50 years faces competing options and possible demise. , 1999, Bipolar disorders.

[40]  F. Hartl.  Molecular chaperones in cellular protein folding , 1996, Nature.

[41]  Bruce A. Davis,et al.  The trace amines and their acidic metabolites in depression — an overview , 1994, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[42]  R. Morimoto,et al.  Complex regulation of heat shock- and glucose-responsive genes in human cells , 1988, Molecular and cellular biology.

[43]  S. Potkin,et al.  Phenylethylamine in paranoid chronic schizophrenia. , 1979, Science.

[44]  A. Coppen,et al.  Decreased cerebrospinal fluid concentration of free phenylacetic acid in depressive illness. , 1979, Clinica chimica acta; international journal of clinical chemistry.

[45]  R. C. Young,et al.  A Rating Scale for Mania: Reliability, Validity and Sensitivity , 1978, British Journal of Psychiatry.

[46]  M. Hamilton.  A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.

[47]  B. Lerer,et al.  Association of the trace amine associated receptor 6 (TAAR6) gene with schizophrenia and bipolar disorder in a Korean case control sample. , 2008, Journal of psychiatric research.

[48]  J. Ormel,et al.  STRESS, NEUROTRANSMITTERS, AND HORMONES: NEUROENDOCRINE AND GENETIC MECHANISMS , 2008 .

[49]  D. Presti,et al.  Endogenous psychoactive tryptamines reconsidered: an anxiolytic role for dimethyltryptamine. , 2005, Medical hypotheses.

[50]  David Goldman,et al.  An expanded evaluation of the relationship of four alleles to the level of response to alcohol and the alcoholism risk. , 2005, Alcoholism, clinical and experimental research.

[51]  F. Hartl,et al.  Molecular chaperone functions of heat-shock proteins. , 1993, Annual review of biochemistry.

[52]  S. Lindquist,et al.  The heat-shock proteins. , 1988, Annual review of genetics.